introduction Hodgkin lymphoma (HL), a mature B-cell-derived cancer, is one of the most common lymphomas. In HL, the tumor cellsHodgkin and Reed-Sternberg cells-have largely lost their Bcell phenotype [1] . Many autoimmune diseases (ADs) share a common B-cell lineage origin with HL. Increased risks of HL associated with a personal history of several ADs, such as rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, and immune thrombocytopenic purpura, are known [2, 3] .
The incidence of several cancer types is increased in patients with ADs for reasons that are not quite clear [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The immunological disturbances in ADs may be important mechanisms to cancer formation because many autoantibodies found in cancer patients are also found in patients with ADs [15] . However, treatment with immunosuppressive therapy may also contribute [16] . Many ADs are treated with anti-inflammatory drugs and as these are protective against some cancers [17] , they may help to hide carcinogenic effects of ADs [18] .
According to the 2008 WHO classification of lymphomas, HL consists of five subtypes: nodular lymphocyte-predominant, nodular sclerosis classical, lymphocyte-rich classical, mixed cellularity classical, and lymphocyte-depleted classical [19, 20] . Classical subtypes differ in presentation, sites of involvement, epidemiology, and association with Epstein-Barr virus [21] . Non-classical nodular lymphocyte-predominant HL has a distinct histological appearance, immunophenotype, clinical presentation, and prognosis as well as significantly different natural history compared with the classical form of HL [22] . On the one hand, HL is more common in men than in women, and its incidence peaks in young adults and in people older than 60 years [21] . On the other hand, about three-fourths of the patients afflicted with ADs are women suggesting that sex differences impact the incidence of AD, although the sex ratio varies depending on the disease [23] . The more frequent the AD and the later it appears, the more women are affected [24] . The AD and HL diagnostics and treatments have changed over the years with improvements in survival. In addition to checking whether other ADs are related to HL in a larger cohort study, we thus aimed to ascertain if the association of HL and ADs differs by histological subtype of HL, sex, age and period at diagnosis of cancer covering the total Swedish population between 1964 and 2010.
materials and methods
The research dataset used in the present study is a subset of a national dataset maintained at the Center for Primary Health Care Research, Lund University, Malmö, Sweden, and has been described elsewhere [8] . In brief, AD patients were identified from nationwide Swedish healthcare data registers, such as the Hospital Discharge Registry, the Outpatient Registry, and the Primary Health Care Registry-the latter with data mainly from Stockholm. The accuracy of AD diagnoses, estimated between 88% and 96%, has been discussed elsewhere [25] . The linkages of these registries to the Swedish Cancer Registry with1.7 million recorded incident primary cancer patients out of 14.7 million people, the Cause-specific Death Register, and national census data were carried out by means of an individual national identification number, which is assigned to each person in Sweden for their lifetime. This number was replaced by a serial number for each person in order to provide anonymity. The study was approved by the regional ethics review board at the Lund University.
The International Classification of Diseases (ICD) with codes for main diagnoses was used to retrieve AD patients (supplementary Table S1 , available at Annals of Oncology online). A total of 33 ADs were covered (supplementary Table S2 , available at Annals of Oncology online). However, there were less than three cases of HL for nine ADs-Addison disease, amyotrophic lateral sclerosis, chorea minor, discoid lupus erythematosus, localized scleroderma, lupoid hepatitis, primary biliary cirrhosis, Reiter's disease, and systemic sclerosis. These diseases were not significantly associated with HL -as assessed by SIR-and data are not shown for them, although they contributed in the estimates for 'All' ADs-last row of each 
sex
The overall SIR of HL after ADs was slightly higher in men (2.4, 2.0-2.7) than in women (1.8, 1.5-2.0; Table 1 ). This increase was mostly attributed to rheumatoid arthritis (4.9, 3.6-6.4 in men versus 2.3, 1.6-3.0 in women, without 95% CI overlap), systemic lupus erythematosus (13.9, 5.9-27.5 versus 6.8, 3.6-11.6; with 95% CI overlap), and autoimmune hemolytic anemia (30.3, 7.9-78.5 versus 11.8, 1.1-43.3; with 95% CI overlap). The higher HL risk in men did not conform to those ADs with male predominant incidence such as rheumatoid fever, ankylosing spondylitis, or Behcet's disease. The SIR for sarcoidosis was slightly lower in men (9.2, 6.2-13.3) than in women (11.8, 7.9-17.1; with 95% CI overlap). Hashimoto thyroiditis/hypothyroidism, as a highly female predominant AD, had about threefold higher risk of HL in men (1.1-6.6; six cases).
interval between AD and HL diagnoses
When we allowed a latency period between AD and HL diagnoses for ≥1 year, the overall SIR for HL after AD decreased from age at diagnosis of HL
The data were also analyzed according to the age at diagnosis of HL (Table 2 ). Most HL patients had been diagnosed at older ages (age ≥ 50). In general, the increased risks of HL for those diagnosed before 35 years (overall SIR 1. histological subtype of HL
In general, the risk of most of HL subtypes-except for nodular lymphocyte predominant-was increased after ADs (Table 3) : lymphocyte depletion 3.7 (1.5-7.6), lymphocyte-rich 3.7 (2.3-5.9), and mixed cellularity 2.4 (1.8-3.2). When there was a larger sample size in the AD-specific analyses, our results showed that ADs do not exclusively associate with a particular histology type of HL, although a tendency toward higher SIRs for lymphocyte depletion and lymphocyte-rich subtypes was notable. For instance, rheumatoid arthritis increased the risk of all classical types of HL: lymphocyte depletion 10.3 (2.0-30.6), lymphocyterich 6.2 (1.6-16.1), mixed cellularity 4.9 (2.6-8.4), and nodular sclerosis 2.6 (1.5-4.3).
mortality due to HL after AD
In a supplementary cause-specific mortality analysis using the Cox proportional regression models, only patients with pernicious anemia (hazard ratio = 4.3, 95%CI 1.6-11.5, n = 4) and Behcet's disease (2.5, 95% CI 1.0-6.0, n = 5) had an increased mortality due to subsequent HL compared with that in those without AD. Due to small sample sizes, these data are not shown or further discussed.
discussion
The present study, benefiting from a nationwide database with a long term follow-up-up to 47 years-showed for the first time associations between HL and several ADs such as autoimmune hemolytic anemia (SIR = 19.9), polyarteritis nodosa (6.6), polymyositis/dermatomyositis (6.3), Behcet's disease (5.6), Sjögren's syndrome (5.0), polymyalgia rheumatica (2.2), and psoriasis (1.9). This cohort study also confirmed the association of some of the already known HL-related ADs (rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, and immune thrombocytopenic purpura), which has been shown in a case-control study on similar Danish and Swedish data with ADs diagnoses from 1964 to 2000 and HL diagnoses from 1958 to 1998 [2, 26] . About one-fourth of our AD and HL patients were included in both studies, but the current study with a cohort design had more power, especially for stratified analyses by sex, age, time period, interval between AD and HL diagnoses, and histology. The novel histology-specific analysis showed no significant difference in ADs toward a specific histological subtype of classical HL, although the overall SIR for nodular sclerosis type was lower than the SIRs for the other HL types. Our findings may suggest that the role of predisposing immune-related factors in the differentiation of histology types of HL after ADs is not as strong as its role in the development of HL as such.
In contrast to the previous case-control study on this subject [2] , our population-based cohort study with a much larger sample size showed a sex difference in the association of AD and HL toward a higher risk of HL in men with ADs than that in female patients with ADs-in line with the sex distribution of HL and in contrast to the sex distribution of ADs in general. In developed countries, the male HL incidence is slightly higher in children, in patients >50 years, in mixed cellularity subtype and in EBV-positive disease [27] . The female HL incidence is higher or equal in adolescents/young adults and in those with nodular sclerosis. In developing countries, male HL incidence is higher than that in women across all age groups [27] .
Our age-specific analyses showed higher overall risks of HL with increasing age-except for sarcoidosis. As patients had a precondition of AD, which mostly occurs in older ages, presumably the cases of HL would be higher in older ages. Therefore, the findings for age were not unexpected. The highest incidence of HL in Western countries occurs in young adults and consists primarily of nodular sclerosis. The main results found in 'older age' HL, which was more common in males and in mixed Although some of the patients were diagnosed with AD or HL several decades ago and some historic diagnoses could be inaccurate, the similar increased risks of HL after AD in two different periods (<1993 and ≥1993) may rule out any bias due to a diagnostic bias. As we tested several ADs in one study, the risk of chance findings due to multiple comparisons could be high. However, many of the ADs have been already associated with HL, so for these ADs, the results were only confirmatory. For the rest of the ADs, confirmatory results of stratified analysesby sex, age, period, histology, and interval-suggest that our results are not due to chance finding.
HL and many autoantibody producing ADs have a common B-cell origin [28, 29] . However, our findings for associations of ADs and HL were not limited to detectable autoantibody producing ADs such as rheumatoid arthritis, Sjögren's syndrome, systemic lupus erythematosus, polymyositis/dermatomyositis, autoimmune hemolytic anemia, and immune thrombocytopenic purpura. Behcet's disease, polymyalgia rheumatica, sarcoidosis, and psoriasis were examples of HL-related ADs in our study that usually do not produce detectable autoantibodies. Therefore, the association between HL and ADs may not be related to autoantibody production per se.
The significant results after allowing a latency period between AD and HL diagnoses indicate that our findings are not due to reverse association or overlap of presenting symptoms between AD and HL, except for polyarteritis nodosa and polymyositis/ dermatomyositis, which may be due to small sample sizes. Higher SIRs in the shorter interval between AD and HL could be due to a systematic surveillance of AD patients, which might have resulted in an earlier diagnosis of HL. However, this association seems to be a two-way street [30] . Both of these diseases can be a consequence of multistep processes that eliminate the checkpoints that inhibit uncontrolled B-cell growth, including uncontrolled growth of autoimmune lymphocytes. Goldin and Landgren [4] have suggested that autoimmunity may lead to both overstimulation and defective apoptosis of B cells. Other possible mechanisms such as secondary inflammation due to autoimmune stimulation, several infections including hepatitis C and Epstein-Barr virus (EBV), and genetic factors predisposing to both ADs and lymphomas may also play a substantial role [31] . HLA region, especially class II, with or without association with EBV has the strongest association with HL risk [32] , and this region has long been associated with genetic risk of ADs [33] . One should note that based on our results, we do not claim a causal relationship between ADs and HL. Investigating risks of ADs after HL warrant further studies.
The present paper is a continuation of a series of studies on cancer risk after ADs, including cancers in the digestive tract and lung, urological, gynecological, and skin cancers as well as Kaposi's sarcoma, Merkel cell carcinoma, multiple myeloma, and leukemia [8] [9] [10] [11] [12] [13] [14] .
In conclusion, several, but not all ADs (11/33), had a positive association with all classical histological subtypes of HL. Higher risks of classical HL after polyarteritis nodosa, polymyositis/ dermatomyositis, Behcet's disease, Sjögren's syndrome, polymyalgia rheumatica, and psoriasis were novel findings of this study. Investigating the exact mechanisms involved in the development of HL and AD may help to better understand the etiology of and control measures of both diseases.
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